Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03054740 · ClinicalTrials.gov registry record · Phase 4
Vapocoolant Spray Used Prior to Intravenous (IV) Insertions
A Phase 4 study, sponsored by Aultman Health Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT03054740 is a Phase 4 study that has completed, run by Aultman Health Foundation. The registered enrollment target is 30 participants.
The verdict
NCT03054740, a Phase 4 study, has completed, sponsored by Aultman Health Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine if by offering a vapocoolant (cold spray) to hospital outpatients prior to an intravenous catheter (IV) insertion will increase patient satisfaction of IV insertion as well as determine if pain of insertion is decreased.
Interventions
- DRUG Gebauer Ethyl Chloride
- DRUG Nature's Tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-02-27 |
| Est. Completion | 2017-04-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03054740
The ClinicalTrials.gov registry entry for NCT03054740 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aultman Health Foundation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gebauer Ethyl Chloride is the first listed.
NCT03054740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03054740 about?
NCT03054740 is a clinical study titled "Vapocoolant Spray Used Prior to Intravenous (IV) Insertions". The primary purpose of this study is to determine if by offering a vapocoolant (cold spray) to hospital outpatients prior to an intravenous catheter (IV) insertion will increase patient satisfaction of IV insertion as well as determine if pain of insertion is decreased.
What is the current status of trial NCT03054740?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2017-02-27. Estimated completion is 2017-04-28.
What interventions are being tested in trial NCT03054740?
The interventions under investigation include: Gebauer Ethyl Chloride (DRUG), Nature's Tears (DRUG).
Who is sponsoring clinical trial NCT03054740?
This trial is sponsored by Aultman Health Foundation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.